$STEV Stevia Corp. Files Provisional Patent with t
Post# of 7060
(Total Views: 160)
Posted On: 08/18/2022 8:12:16 AM
$STEV Stevia Corp. Files Provisional Patent with the United States Patent and Trademark Office for the Treatment of Symptoms Associated with BPH (Benign Prostatic Hyperplasia)
Stevia Corp. (OTC PINK:STEV) ("Stevia Corp" or the "Company"
, a healthcare company focused on the commercial development of products that support a healthy lifestyle announced today that the company has filed a provisional patent with the United States Patent and Trademark Office for a proprietary herbal supplement formula for the treatment of BPH and symptoms related to BPH (Benign Prostatic Hyperplasia). At the present time and to protect the claims and integrity of the provisional patent, Stevia Corp. is not publicly identifying the components of the herbal supplement formula. The provisional patent was assigned application number 63/370,673 by the USPTO.
More than 40,000,000 men at any time in the United States have BPH. BPH (a/k/a benign prostatic hyperplasia or enlarged prostate) predominantly affects men over the age of 50. BPH is the most common medical condition in males over 50 worldwide. In 2000, a study estimated there were over 11,000,000 new cases of BPH reported worldwide each year. BPH symptoms include difficulty in urinating, difficulty in completely emptying the bladder, slow or intermittent urination stream, and sudden urges to urinate although the bladder is not full.
BPH is initially diagnosed by a general practitioner or a urologist. If the doctor determines that your prostate is enlarged, he or she may order a full battery of tests including a urinalysis, PVR, uroflowmetry and/or a urodynamic pressure flow study. The doctor may also order different imaging scans including ultrasounds, cystoscopy and MRI.
BPH is treated either non-invasively, surgically or through prescription medicine. Non-invasive treatments can include microwave therapy, transurethral needle ablation, laser therapy or laser vaporization. Surgical procedures include transurethral needle ablation, laser surgery, open prostatectomy and transurethral incision of the prostate. Most drug treatments for BPH include a class of drugs called alpha blockers and inhibitors. Although these drugs have efficacy in a certain percentage of the BPH population, they also have a significant side effect profile. Most not invasive therapies for BPH have no or limited effect. Surgical treatments are effective and are generally safe, but complications can include bleeding, infection, incontinence, and impotence.
https://finance.yahoo.com/news/stevia-corp-fi...00462.html
Stevia Corp. (OTC PINK:STEV) ("Stevia Corp" or the "Company"
, a healthcare company focused on the commercial development of products that support a healthy lifestyle announced today that the company has filed a provisional patent with the United States Patent and Trademark Office for a proprietary herbal supplement formula for the treatment of BPH and symptoms related to BPH (Benign Prostatic Hyperplasia). At the present time and to protect the claims and integrity of the provisional patent, Stevia Corp. is not publicly identifying the components of the herbal supplement formula. The provisional patent was assigned application number 63/370,673 by the USPTO. More than 40,000,000 men at any time in the United States have BPH. BPH (a/k/a benign prostatic hyperplasia or enlarged prostate) predominantly affects men over the age of 50. BPH is the most common medical condition in males over 50 worldwide. In 2000, a study estimated there were over 11,000,000 new cases of BPH reported worldwide each year. BPH symptoms include difficulty in urinating, difficulty in completely emptying the bladder, slow or intermittent urination stream, and sudden urges to urinate although the bladder is not full.
BPH is initially diagnosed by a general practitioner or a urologist. If the doctor determines that your prostate is enlarged, he or she may order a full battery of tests including a urinalysis, PVR, uroflowmetry and/or a urodynamic pressure flow study. The doctor may also order different imaging scans including ultrasounds, cystoscopy and MRI.
BPH is treated either non-invasively, surgically or through prescription medicine. Non-invasive treatments can include microwave therapy, transurethral needle ablation, laser therapy or laser vaporization. Surgical procedures include transurethral needle ablation, laser surgery, open prostatectomy and transurethral incision of the prostate. Most drug treatments for BPH include a class of drugs called alpha blockers and inhibitors. Although these drugs have efficacy in a certain percentage of the BPH population, they also have a significant side effect profile. Most not invasive therapies for BPH have no or limited effect. Surgical treatments are effective and are generally safe, but complications can include bleeding, infection, incontinence, and impotence.
https://finance.yahoo.com/news/stevia-corp-fi...00462.html
(0)
(0)